- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03437980
Propofol Spinal Procedural Sedation for Cesarean Section
Can Propofol Procedural Sedation Implementation Increase the Acceptance of Spinal Anesthesia During Cesarean Section?
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Dakahlya
-
Mansourah, Dakahlya, Egypt, 35516
- Delta Hospital
-
Mansourah, Dakahlya, Egypt, 35516
- Mansoura University Hospital
-
-
Sharkya
-
Zagazig, Sharkya, Egypt, 44519
- Zagazig University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients scheduled for elective cesarean section,
- Age: 18 - 40 years,
- American Society of Anesthesiologists I - III,
- Patients may present any of the following conditions:
- Respiratory diseases as bronchial asthma
- Hepatic compromise,
- Preeclampsia,
- Anemia with hemoglobin 10 g/dl,
- Previous sections,
- Obese with BMI more than 35%,
- Any criteria of difficult intubation, Compromised fetus as premature delivery, History of complications or non-satisfaction after general anesthesia during previous cesarean section,
Exclusion Criteria:
- Patients refusing to participate in the study,
- Known psychiatric disease,
- Addiction medications,
- Communication barrier,
- Absolute or relative contraindication for spinal anesthesia,
- Bad obstetric history, complicated pregnancy, congenital fetal anomaly.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: propofol spinal acceptance
The surgeon and the anesthetist will discuss the exclusion criteria. Then they will discuss the information's about spinal and general anesthesia with the illegible patients, also reply the patient's questions in a preoperative visit. The primary decision for the patient; either spinal or general anesthesia will be recorded. The patients refusing spinal anesthesia will be discussed again to detect the rate of acceptance of spinal anesthesia if propofol sedation is ensured during the procedure to provide a painless spinal injection. The final decision will be applied; either spinal with procedural sedation, or general anesthesia. |
A bolus of 0.7 mg/kg will be given initially, additional incremental doses of 20 mg propofol will be given if the patient complained of pain or moved arms towards the back.
Patients will be sitting on the middle of the operating table facing towards the table's foot.
The table's foot will be dropped 45 degrees for a comfortable chair position, Monitoring through pulse oximeter (SaO2), non-invasive blood pressure (NIBP) adjusted every 2 minutes automatic measuring and capnography tube in contact with nostrils.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The rate of acceptance of spinal anesthesia if propofol sedation is added during the procedure.
Time Frame: 30 minutes preoperative.
|
percent
|
30 minutes preoperative.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The rate of initial acceptance of spinal anesthesia without sedation.
Time Frame: 30 minutes preoperative.
|
percent
|
30 minutes preoperative.
|
The anxiety score.
Time Frame: 30 minutes preoperative,10 minutes after spinal injection, and 30 minutes after stay at recovery room.
|
by the visual analogue score from 0-10, where 10 is the maximum anxiety level.
|
30 minutes preoperative,10 minutes after spinal injection, and 30 minutes after stay at recovery room.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The patient satisfaction regards the spinal anesthesia decision.
Time Frame: 30 minutes at recovery room.
|
The patients express thier satisfaction with the spinal decision on a visual analogue score, ranging from 0 to 10, where 0 is the minimum and 10 is the maximum satisfaction level.
|
30 minutes at recovery room.
|
The total utilized dose of propofol.
Time Frame: 1 minute after completion of spinal procedure, and 5 minutes at the end of cesarean section.
|
milligram
|
1 minute after completion of spinal procedure, and 5 minutes at the end of cesarean section.
|
The rate of premature termination of spinal procedure (failure rate).
Time Frame: 20 minutes preoperative.
|
percent
|
20 minutes preoperative.
|
The sedation score.
Time Frame: determined 1 minutes after following spinal injection. then again after 10 minutes.
|
using modified Ramsay scale, 1. Anxious, 2. Cooperative, oriented, tranquil.
3. Responsive to commands only.
If Asleep.
4. Brisk response to light glabellar tap or loud auditory stimulus.
5. Sluggish response to light glabellar tap or loud auditory stimulus.
|
determined 1 minutes after following spinal injection. then again after 10 minutes.
|
The infant Apgar score.
Time Frame: 0 and 5 minutes after delivery.
|
A measure of the physical condition of a newborn infant.
Adding points (2, 1, or 0) for heart rate, respiratory effort, muscle tone, response to stimulation, and skin coloration; ranges from 0- 10, score of ten represents the best possible condition.
|
0 and 5 minutes after delivery.
|
Patient's choice of anesthesia next time.
Time Frame: 30 minutes after shifting the patient to recovery room.
|
spinal or general anesthesia.
|
30 minutes after shifting the patient to recovery room.
|
The incidence of desaturation during propofol spinal procedural sedation.
Time Frame: 20 minutes preoperative.
|
in percent, desaturation defined as oxygen saturation less than 90%
|
20 minutes preoperative.
|
The incidence of hypotension during propofol spinal procedural sedation.
Time Frame: 20 minutes preoperative.
|
in percent, hypotension defined as mean blood pressure less than 60 millimeter mercury.
|
20 minutes preoperative.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R.18.02.23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Compliance
-
HaEmek Medical Center, IsraelUnknownPatient Satisfaction | Patient Compliance
-
University of AarhusUnknownPatient Engagement | Patient Empowerment | Patient Compliance
-
University of Illinois at Urbana-ChampaignNational Institute on Aging (NIA)Completed
-
Coloplast A/SCompletedCompliance, PatientDenmark
-
Arizona State UniversityNational Institute on Drug Abuse (NIDA); Mesa Public SchoolsCompletedPatient ComplianceUnited States
-
Norwegian Medical AssociationCompleted
-
Columbia AsiaCompletedPatient Compliance | Physician-Patient RelationsIndia
-
Xijing Hospital of Digestive DiseasesRecruiting
-
Shara Qadir HusseinCompleted
-
University of CalgaryCompleted
Clinical Trials on propofol
-
Hopital FochCompleted
-
Konkuk University Medical CenterCompletedCoronary Artery Disease | Valvular Heart DiseaseKorea, Republic of
-
University Medical Center GroningenCompletedAnesthesia | Hemodynamic Instability | Interaction | Disorder of Oxygen TransportNetherlands
-
Asan Medical CenterCompletedPopulation Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy VolunteersHealthyKorea, Republic of
-
Tiva GroupMedtronic - MITGCompleted
-
Pontificia Universidad Catolica de ChileCompletedSurgery | Anesthesia | Depth of Anesthesia | NeonateChile
-
KVG Medical College and HospitalUnknown
-
Acibadem UniversityCompleted
-
Hopital FochCompleted